Titlebook: Cellular Therapies for Retinal Disease; A Strategic Approach Steven D. Schwartz,Aaron Nagiel,Robert Lanza Book 2017 Springer International

調(diào)停

書目名稱Cellular Therapies for Retinal Disease影響因子(影響力)




書目名稱Cellular Therapies for Retinal Disease影響因子(影響力)學(xué)科排名




書目名稱Cellular Therapies for Retinal Disease網(wǎng)絡(luò)公開度




書目名稱Cellular Therapies for Retinal Disease網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Cellular Therapies for Retinal Disease被引頻次




書目名稱Cellular Therapies for Retinal Disease被引頻次學(xué)科排名




書目名稱Cellular Therapies for Retinal Disease年度引用




書目名稱Cellular Therapies for Retinal Disease年度引用學(xué)科排名




書目名稱Cellular Therapies for Retinal Disease讀者反饋




書目名稱Cellular Therapies for Retinal Disease讀者反饋學(xué)科排名

尖叫

Scope of services to be outsourced, RPE monolayer and facilitate manipulation and subretinal implantation. An ideal scaffold should mimic the properties of the natural RPE substrate: Bruch’s membrane. It should have a similar thickness, flexibility, micro- and macromolecule permeability, and the ability to promote survival, polarity,

Synovial-Fluid

hurricane

跳脫衣舞的人

波動(dòng)

Book 2017t of surgically delivered cellular therapies. Having an in-depth understanding ofthe current state of cell therapy for the eye is an essential first step toward utilizing similar approaches in other organs. Ophthalmologists, translational clinician-scientists, stem cell scientists, and researchers i

波動(dòng)

飛鏢

Pericarditis

Subretinal Delivery of Cells via the Suprachoroidal Space: Janssen Trialtes to the subretinal space. After considering a number of potential techniques, they developed a novel approach using the suprachoroidal space as a conduit to the posterior pole. This approach involves the creation of a sclerotomy, introduction of a specialized cannula into the suprachoroidal space

紅潤

Retinal Organoids: An Emerging Technology for Retinal Disease Research and Therapyoes not reproduce that of late fetal development. However, studies to date suggest that immature photoreceptor or retinal ganglion cells, roughly those of mid-gestation, function best for transplantation. This developmental stage appears to be well reproduced in vitro, and therefore the PSC-derived